TY - JOUR
T1 - Potent activation of large-conductance Ca2+-activated K + channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl) phenyl]urea (NS1643) in pituitary tumor (GH3) cells
AU - Wu, Sheng Nan
AU - Peng, Hsung
AU - Chen, Bing Shuo
AU - Wang, Ya Jean
AU - Wu, Pei Yu
AU - Lin, Ming Wei
PY - 2008/12
Y1 - 2008/12
N2 - 1,3-Bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) is reported to be an activator of human ether-à-go-go-related gene current. However, it remains unknown whether it has any effects on other types of ion channels. The effects of NS1643 on ion currents and membrane potential were investigated in this study. NS1643 stimulated Ca2+-activated K+ current [IK(Ca)] in a concentration-dependent manner with an EC50 value of 1.8 μM in pituitary tumor (GH3) cells. In inside-out recordings, this compound applied to the intracellular side of the detached channels stimulated large-conductance Ca2+-activated K+ (BKCa) channels with no change in single-channel conductance. It shifted the activation curve of BKCa channels to less depolarized voltages without altering the gating charge of the channels. NS1643-stimulated channel activity depended on intracellular Ca2+, and mean closed time during exposure to NS1643 was reduced. NS1643 (3 μM) had little or no effect on peak amplitude of ether-à-go-go-related gene-mediated K+ current evoked by membrane hyperpolarization, although it increased the amplitude of late-sustained components of K+ inward current, which was suppressed by paxilline but not by azimilide. NS1643 (3 μM) had no effect on L-type Ca2+ current. This compound reduced repetitive firing of action potentials, and further application of paxilline attenuated its decrease in firing rate. In addition, NS1643 enhanced BKCa-channel activity in human embryonic kidney 293T cells expressing α-hSlo. In summary, we clearly show that NS1643 interacts directly with the BKCa channel to increase the amplitude of IK(Ca) in pituitary tumor (GH3) cells. The α-subunit of the channel may be a target for the action of this small compound.
AB - 1,3-Bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) is reported to be an activator of human ether-à-go-go-related gene current. However, it remains unknown whether it has any effects on other types of ion channels. The effects of NS1643 on ion currents and membrane potential were investigated in this study. NS1643 stimulated Ca2+-activated K+ current [IK(Ca)] in a concentration-dependent manner with an EC50 value of 1.8 μM in pituitary tumor (GH3) cells. In inside-out recordings, this compound applied to the intracellular side of the detached channels stimulated large-conductance Ca2+-activated K+ (BKCa) channels with no change in single-channel conductance. It shifted the activation curve of BKCa channels to less depolarized voltages without altering the gating charge of the channels. NS1643-stimulated channel activity depended on intracellular Ca2+, and mean closed time during exposure to NS1643 was reduced. NS1643 (3 μM) had little or no effect on peak amplitude of ether-à-go-go-related gene-mediated K+ current evoked by membrane hyperpolarization, although it increased the amplitude of late-sustained components of K+ inward current, which was suppressed by paxilline but not by azimilide. NS1643 (3 μM) had no effect on L-type Ca2+ current. This compound reduced repetitive firing of action potentials, and further application of paxilline attenuated its decrease in firing rate. In addition, NS1643 enhanced BKCa-channel activity in human embryonic kidney 293T cells expressing α-hSlo. In summary, we clearly show that NS1643 interacts directly with the BKCa channel to increase the amplitude of IK(Ca) in pituitary tumor (GH3) cells. The α-subunit of the channel may be a target for the action of this small compound.
UR - http://www.scopus.com/inward/record.url?scp=57349087797&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=57349087797&partnerID=8YFLogxK
U2 - 10.1124/mol.108.049106
DO - 10.1124/mol.108.049106
M3 - Article
C2 - 18809671
AN - SCOPUS:57349087797
SN - 0026-895X
VL - 74
SP - 1696
EP - 1704
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -